Xconomy

SEPTEMBER 27, 2016

[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

AUGUST 17, 2016

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. and San Diego’s Avalon Ventures.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

NOVEMBER 19, 2017

ScoreStream, a five-year-old startup that created a social media platform for crowd-sourcing local sports scores, has raised $3.7 million in a Series A round that includes Intel Capital as an investor.

Avalon 56

Avalon Invest Social Media Media 56

Xconomy

JULY 20, 2016

First came Inception Sciences , a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. It’s a little like what Avalon is doing. We are definitely interested in oncology, but there is no value in disclosing details.”. But it’s structured differently.

San Diego 40

San Diego Avalon Outsource Development Newsletter 40

Xconomy

JULY 10, 2016

Larry’s diagnosis was cancer with a big C: “I have stage 4 pancreatic cancer and have been on chemo since June with some ups and downs,” he wrote in mid-March. He found he didn’t enjoy being a traditional VC gatekeeper who said “yes” or “no” to startup pitches, according to his wife, Diane. “He They had a lot of fun.”.

San Diego 40

San Diego Startup Avalon Venture Capital 40

Xconomy

JULY 19, 2016

Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. They can’t be made efficiently and at low cost.”.

San Diego 40

San Diego Avalon Research Examples 40